The novel acid pump antagonists for anti-secretory actions with their peculiar applications beyond acid suppression

Journal of Clinical Biochemistry and Nutrition

Volumn 38, Issue 1, 2006, Pages 1-8

  Yeo, Marie ^a   Kwak, Mi Sun ^a   Kim, Dong Kyu ^a   Chung, In Sik ^b   Moon, Byoung Seok ^c   Song, Keun Seog ^c   Hahm, Ki Baik ^a  

^a Ajou University School of Medicine   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c Yuhan Corporation   (South Korea)

Author keywords

Acid pump; APA; Gastric acid secretion; Helicobacter pylori; PPI

Indexed keywords

1 (2 METHYLPHENYL) 4 METHYLAMINO 6 METHYL 2,3 DIHYDROPYRROLO(3,2 C)QUINOLINE; 2,3 DIMETHYL 8[(4 AZIDOPHENYL)METHOXY]IMIDAZO[1,2]PYRIDINE; 8 BENZYLOXY 2 METHYLIMIDAZO[1,2 A]PYRIDINE 3 ACETONITRILE; ACETYLCHOLINE; ANTIHISTAMINIC AGENT; BY 841; CYCLIC AMP; GASTRIN RELEASING PEPTIDE; HYDROGEN POTASSIUM ADENOSINE TRIPHOSPHATASE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; LANSOPRAZOLE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 3; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; OSOMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR; PYRIDINE DERIVATIVE; QUINOLINE DERIVATIVE; RABEPRAZOLE; REVAPRAZAN; REVAPRAZOLE; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; CANCER CELL; CLINICAL TRIAL; DRUG BINDING; DRUG EFFICACY; DRUG HALF LIFE; DRUG INHIBITION; DRUG MECHANISM; DRUG STRUCTURE; GASTROESOPHAGEAL REFLUX; HUMAN; KINETICS; MOLECULAR WEIGHT; PEPTIC ULCER; PH; PRESCRIPTION; REVIEW; STOMACH ACID SECRETION; STOMACH PARIETAL CELL;

HELICOBACTER PYLORI;

EID: 33645762920     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.38.1     Document Type: Review

References (29)

1. Modlin, I. M. and Sach, S. G.: Acid related diseases; biology and treatment, 2nd Edit, Lippincott, Williams & Wilkins, 2004.
2. Davies, R. E.: The mechanism of hydrochloric acid production by the stomach. Biol. Rev., 26, 87, 1951.
3. 3 exchange in gastric parietal cells. Cell Regal., 2, 727-737, 1991.
4. Yao, X. and Forte, J. G: Cell biology of acid secretion by the parietal cell. Ann. Rev. Physiol., 65, 103-131, 2003.
5. Wolfe, M. M. and Sachs, G: Acid suppression: optimizing therapy for gastroduodenal ulcer healing, gastroesophageal reflux disease, and Stress-related erosive syndrome. Gastroenterology, 118, S9-S31, 2000.
6. Robinson, M.: Proton pump inhibitors: update on their role in acid-related gastrointestinal diseases. Int. J. Clin. Pract., 59, 709-715, 2005.
7. 2 receptor antagonists and anticholinergics. Pharmacol. Res., 21, 339, 1989.
8. 2 receptor antagonists. N. Engl. J. Med., 323, 1672, 1990.
9. Modlin, I. M.: From prout to the proton pump-a history of the science of gastric acid secretion and the surgery of peptic ulcer. Surg. Gynecol. Obstet., 170, 81-96, 1990.
10. Horn, J.: The proton-pump inhibitors: Similarities and differences. Clinical. Therapeutics, 22, 266-279, 2000.
11. +-ATPase. J. Physiol. Paris., 94, 19-23, 2000.
12. +-competitive photoaffinity inhibitor. Biochemistry, 27, 3932-3938, 1988.
13. +-competitive fluorescent inhibitor of the H,K-ATPase. J. Biol. Chem., 266, 12395-12401, 1991.
14. + access to the ion binding domain. Biochemistry, 41, 12755-12762, 2002.
15. Yeo, M., Kim, D. K., Kim, Y. B., Oh, T. Y., Lee, J. E., Cho, S. W., Kim, H. C., and Hahm, K. B.: Selective induction of apoptosis with proton pump inhibitor inhibits tumor cell growth in gastric cancer cells; novel application of proton pump inhibitor for chemoprevention. Clinical Cancer Research, 10, 8687-8696, 2004.
16. Yeo, M., Kim, D. K., Han, S. U., Lee, J. E., Kim, Y. B., Cho, Y., Kim, J. H., Cho, S. W., and Hahm, K. B.: Novel action of gastric proton pump inhibitor on the suppression of Helicobacter pylori-induced angiogenesis. Gut., In press
17. Prinz C., Kajimura M., Scott D. R., et al.: Histamine secretion from rat enterochromaffin-like cells. Gastroenterology, 105, 449, 1993.
18. Ash, A. and Schild, H.: Receptors mediating some of the actions of histamine. Br. J. Pharmacol., 27, 427-439, 1966.
19. Dibona, D. R., Ito, S., Berglindh, T., et al.: Cellular site of gastric acid secretion. Proc. Natl. Acad. Sci. USA, 76, 6689, 1979.
20. Rabon, E. C. and Reuben, M. A.: The mechanism and structure of the gastric H, K-ATPase. Ann. Rev. Physiol., 52, 321-344, 1990.
21. +-ATPase. Biochem. Biophys. Res. Commun., 157, 203-209, 1988.
22. +-ATPase. J. Biol. Chem., 261, 16788-16791, 1986.
23. Glynn, I. M. and Karlish, S. J.: Occluded cations in active transport. Annu. Rev. Biochem., 59, 171-205, 1990.
24. +-ATPase in situ: evidence for compartmentalization. Am. J. Physiol., 257(4 Pt 1), G539-G547, 1989.
25. Sachs, G.: Gastritis, Helicobacter pylori and proton pump inhibitors. Gastroenterology, 112, 1033-1036, 1997.
26. Axon, A. T.: Eradication of Helicobacter pylori. Scand. J. Gastroenterol., 31, 47-53, 1996.
27. Forte, T. M., Machen, T. E., and Forte, J. G.: Ultrastructural changes in oxyntic cells associated with secretory function: a membrane-recycling hypothesis. Gastroenterology, 73(4 Pt 2), 941-955, 1997.
28. Yu, K. S., Bae, K. S., Shon, J. H., Cho, J. Y., Yi, S. Y., Chung, J. Y., Lim, H. S., Jang, I. J., Shin, S. G., Song, K. S., and Moon, B. S.: Pharmacokinetic and pharmacodynamic evaluation of a novel proton pump inhibitor, YH1885, in health volunteers. J. Clin. Pharmacol., 44, 73-82, 2004.
29. Chung, I. S., Choi, M., Park, S., Kim, S., Chang, R., Hyun, J., Han, S., Song, G., Shim, C., Hahm, K. B., Kim, H., and Joo, S.: Revaprazan, a novel acid pump antagonist, for duodenal ulcer: results of a double-blind, randomized, parallel, multicenter phase III clinical trial. Korean J. Gastrointest Endosc., 31: 17-24, 2005.